Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of eldecalcitol in postmenopausal women with low bone
mineral density (BMD) or mild osteoporosis through a randomized, open-label, parallel
controlled trial with calcitriol as the control.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Jiao Tong University Affiliated Sixth People's Hospital